Google Cloud's Multiomics Suite Delivers Powerful AI and Bioinformatics Tools for Biotech Companies, Pharmaceutical Firms, and Public Sector Organizations DALLAS, TX / ACCESSWIRE / May 17, 2023 / Form ...

SAN CARLOS, CA / ACCESS Newswire / May 11, 2026 / Form Bio, a leader in AI-powered genetic medicine development and genome engineering, today announced the launch of FormManufacturing™, a new platform ...

SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...

In the midst of an ongoing growth strategy, Form Bio hired Mark Swendsen as Chief Revenue Officer. The computational life sciences platform company, which officially launched late last month, is ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

DALLAS (August 9, 2023) — Form Bio, the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023. The company’s ...

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. This partnership brings together GENEWIZ's industry-leading ...

Newly Created Form Bio Raises $30M Series A Funding Led by JAZZ Venture Partners to empower life scientists with a complete platform for managing large datasets, executing verified workflows, ...

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...

Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research Professionals SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced ...